The Right to Refuse Medication: Navigating the Ambiguity

Psychiatric Rehabilitation Journal

Volumn 21, Issue 3, 1998, Pages 241-249

  Barrett, Karen E ^a   Taylor, Darrell W ^b   Pullo, Robert E ^a   Dunlap, Douglas A ^a  

^a UNIVERSITY OF MAINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346614397     PISSN: 1095158X     EISSN: None     Source Type: Journal    
DOI: 10.1037/h0095307     Document Type: Article

References (45)

1. American Counseling Association, (ACA). (1995). American Counseling Association Codes of Ethics and Standards of Practice. Counseling Today, June, 33-40.
2. Appelbaum, P. S. (1988). The right to refuse treatment with antipsychotic medication: Retrospect and prospect. The American Journal of Psychiatry, 145(4), 413-419.
3. Beck, J. C. (1987). Right to refuse antipsychotic medication: Psychiatric assessment and legal decision making. Mental and Physical Disability Law Reporter, 11(5), 368-372.
4. Beis, E. B. (1984). Mental health and the law. Rockville, MD: Aspen Publication. 153-178.
5. Benshoff, J. J., & Barrett, K. E. (1995). Future of rehabilitation. In A. E. Dell Orto & R. P. Marinelli (Eds.), Encyclopedia of disability and rehabilitation (pp. 333-338). New York, NY: Simon & Schuster Macmillan.
6. Bentley, K. J. (1993). The right of psychiatric patients to refuse medication: Where should social workers stand? Social Work, 38(1), 101-106.
7. Bilder, R. M., Turkel, E., Lipschutz-Broch, L., & Lieberman, J. A. (1992). Antipsychotic medication effects on neuropsychological functions. Psychopharmacology Bulletin, 28(4), 353-366.
8. Blair, D. T., & Dauner, A. (1992). Extrapyramidal symptoms are serious side effect of antipsychotic medication and other drugs. The Nurse Practitioner, 17(11), 56.
9. Blaska, B. (1990). The myriad of medication mistakes in psychiatry: A consumer's view. Hospital and Community Psychiatry, 41(9), 993-998.
10. Boyd, R. D. (1993). Neuroleptic malignant syndrome and mental retardation: Review and analysis of 29 cases. American Journal on Mental Retardation, 98(1), 143-155.
11. Burn, D. (1992). Ethical implications in cross-cultural counseling and training. Journal of Counseling and Development, 70, 578-583.
12. Callahan, L. A. (1986). Changing mental health law: Butting heads with a billy-goat. Behavioral Science Law, 4, 305-314.
13. Case Law Developments. (1986). Informed consent for psychiatric treatments upheld: Right to refuse drug treatments. Mental and Physical Disability Law Reporter, 10(4), 284.
14. Cayleff, S. E. (1986). Ethical issues in counseling gender, race, and culturally distinct groups. Journal of Counseling and Development, 64, 345-347.
15. Corrigan, P. W., Liberman, R. P., & Engel, J. D. (1990). From noncompliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry, 41(11), 1203-1211.
16. Culver, C. M. (1991). Health care ethics and mental health law. In S. A. Shah & B. D. Sales (Eds.), Law and mental health (pp. 25-47). Rockville, MD: U.S. Dept. of Health and Human Services, National Institute of Mental Health.
17. Davison, G. C., & Neale, J. M. (1990). Abnormal psychology (5th Ed)., New York: John Wiley & Sons.
18. Hoge, S. K., Appelbaum, P. S., Lawlor, T., Beck, J. C., Litman, R., Greer, A., Gutheil, T. G., & Kaplan, E. (1990). A prospective, multicenter study of patients' refusal of antipsychotic medication. Archives of General Psychiatry, 47(10), 949-956.
19. Jeste, D. V., & Caligiuri, M. P. (1993). Tardive dyskinesia. Schizophrenia Bulletin, 19(2), 303-315.
20. Kane, J. M., & Marder, S. R. (1993). Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin, 19(2), 287-302.
21. Lazarus, A. (1985). Neuroleptic malignant syndrome: Detection and management. Psychiatric Annals, 15, 706-712.
22. Leff, J. P. (1987a). A model of schizophrenic vulnerability to environmental factors. In H. Hafner, W. F. Gataz & W. Janzarik (Eds.), Search for the causes of schizophrenia (pp. 317-320). Berlin: Springer-Verlag.
23. Leff J. P. (1987b). The influence of life events and relatives' expressed emotion on the course of schizophrenia. In D. Magnusson & A. Ohman (Eds.), Psychopathology: An international perspective (pp. 59-76). New York: Academic Press.
24. Lewine, R. J. (1990). A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. American Journal of Psychiatry, 147(11), 1463-1466.
25. Luchins, D. J., Dojka, D. M., & Hanrahan, P. (1993). Factors associated in the reduction in antipsychotic medication dosage in adults with mental retardation. American Journal on Mental Retardation, 98(1), 165-172.
26. Lundervold, D. A., & Lewin, L. M. (1992). Behavior analysis and therapy in nursing homes. Springfield, IL: Charles C. Thomas.
27. McGinn, F., Flowers, C. R., & Rubin, S. E., (1994). In quest of an explicit multicultural emphasis in ethical standards for rehabilitation counselors. Rehabilitation Education, 7, 261-268.
28. Mental Health Systems Act of 1980. P.L. 96-398, Title III. Rights and Advocacy, Part A, paragraph 4.
29. Perlman, B. B. (1987). Prosecuting patients. [Letter to the Editor]. Hospital and Community Psychiatry, 38(6), 673.
30. Public Health and Welfare, Ch. 102 Mental Health Systems, 42 section 9501: Subchapter IV - Mental Health Rights and Advocacy, "Bill of Rights."
31. Rachlin, S. (1989). Rethinking the right to refuse treatment. Psychiatric Annals, 19(4), 213-222.
32. Reisner, R. (1985). Law and the mental health system: Civil and criminal aspects. St. Paul: West Publishing.
33. Rennie v. Klein, 653 F. 2d 386 (1981), 720 F. 2d 266 (3d Cir 1983).
34. Rivers v. Katz, 67 N.Y. 2d 485 (1986).
35. Rogers v. Okin, 478 F. Supp 1342 (D Mass, 1979).
36. Rosebush, P. (1990). Neuroleptic malignant syndrome: What we know in 1990. Currents, 9, 5-12.
37. Rosenson, M. K. (1993). Social work and the right of psychiatric patients to refuse medication: A family advocate's response. Social Work, 38(1), 107-112.
38. Rubin, S. E., Pusch, B. D., Fogarty, C., & McGinn, F. (1995). Enhancing the cultural sensitivity of rehabilitation counselors. Rehabilitation Education, 9(4), 253-264.
39. Schwartz, J. I., Vingiano, W., & Perez, C. B. (1988). Autonomy and the right to refuse treatment: Patients' attitudes after involuntary medication. Hospital and Community Psychiatry, 39, 1049-1054.
40. Smith, S. R., & Meyer, R. G. (1987). Law, behavior, and mental health: Policy and practice. New York: New York University Press.
41. Szasz, T. S. (1963). Law, liberty, and psychiatry. New York: Macmillan.
42. Szasz, T. S. (1965). Psychiatric justice. New York: Macmillan.
43. Torrey, E. F. (1995) (3rd ed.). Surviving schizophrenia: A manual for families, consumers, and providers. New York: Harper Perennial.
44. Ventura, J., Nuechterlein, K. H., Pederson-Hardesty, J., & Gitlin, M. (1992). Life events and schizophrenic relapse after withdrawal of medication. British Journal of Psychiatry, 161, 615-620.
45. Watson, A. L. (1988). Importance of cross-cultural counseling in rehabilitation counseling curricula. Journal of Applied Rehabilitation Counseling, 19(4), 55-64.